Hims & Hers Health, Inc. (HIMS) Tops Q2 EPS by 2c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Hims & Hers Health, Inc. Reports Second Quarter 2023 Financial Results and Raises Full Year 2023 Outlook
August 7, 2023 4:15 PM EDTRevenue of $207.9 million, up 83% year-over-year in Q2 2023
Net loss of $7.2 million; Adjusted EBITDA profitability of $10.6 million in Q2 2023
Subscribers grew to 1.3 million, up 74% year-over-year in Q2 2023
Raises full year 2023 revenue guidance to a range of $830 million to $850 million and Adjusted EBITDA guidance to a range of $35 million to $40 million
SAN FRANCISCO--(BUSINESS WIRE)-- Hims & Hers Health, Inc. (Hims & Hers or the Company, NYSE: HIMS), the leading health and wellness platform, today reported financial results for the second quarter... More
